SEPN · Septerna, Inc. · Executive Compensation
$38.37
+1.47 (+3.98%)
At close · Oct 9
Return incl. dividend (before tax)
Market Cap
$1.79B
Shares
46.68M
Volume · Oct 9
349.48K
Avg daily vol (3M)
389.91K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Gil M. Labrucherie | CFA, J.D. Chief Financial Officer | $3,240,351 |
| Jeffrey Finer | M.D., Ph.D Chief Executive Officer | $2,933,339 |
| Liz Bhatt | M.S., M.B.A President and Chief Operating Officer | $1,590,770 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jeffrey Finer | M.D., Ph.D. Chief Executive Officer | $4,720,413 |
| Jae B. Kim | Chief Medical Officer | $1,869,558 |
| Liz Bhatt | M.S., M.B.A. Chief Operating Officer | $1,618,661 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jeffrey Finer | M.D., Ph.D. Chief Executive Officer | $2,136,260 |
| Liz Bhatt | M.S., M.B.A. Chief Operating Officer | $883,696 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Keith Gottesdiener, M.D. | member of the Compensation Committee of the Board | Appointed | 2025-09-29 |
| Keith Gottesdiener, M.D. | member of the Board and as a Class I director | Appointed | 2025-09-29 |
| Liz Bhatt, M.S., M.B.A. | President | Appointed | 2025-08-04 |
| Ran Xiao | Interim Chief Financial Officer, principal financial officer and principal accounting officer | Resigned | 2025-01-06 |
| Gil M. Labrucherie | Chief Financial Officer, principal financial officer and principal accounting officer | Appointed | 2025-01-06 |